Bayer | BAYN - Loan Capital


Bayer reported EUR30.68B in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Air Liquide EUR 11.06B 1.39B Dec/2025
Akzo Nobel EUR 4.76B 1.09B Mar/2026
Alcon AG USD 4.16B 434M Mar/2026
Arkema EUR 3.81B 6.6M Mar/2026
AstraZeneca USD 25.96B 177M Mar/2026
BASF EUR 18.48B 447M Dec/2025
Bayer EUR 30.68B 1.15B Mar/2026
Beiersdorf EUR 117M 15M Dec/2025
Corteva USD 1.68B 4M Mar/2026
Covestro EUR 1.67B 408M Dec/2025
Essilor EUR 9.46B 92M Dec/2025
Fresenius EUR 9.22B 1.58B Dec/2025
Fresenius Medical Care EUR 5.74B 895.27M Mar/2026
Genmab DKK 5.14B 5.01B Dec/2025
Givaudan CHF 4.19B 448M Dec/2025
GlaxoSmithKline GBP 14.01B 696M Mar/2026
GRIFOLS EUR 9.08B 612M Mar/2026
Henkel EUR 1.38B 627M Dec/2025
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Johnson Matthey GBP 1.35B 2M Jun/2026
Linde USD 20.68B 2.09B Dec/2025
Lonza CHF 3.88B 323M Dec/2025
Merck EUR 10.8B 72M Mar/2026
Novartis USD 37.45B 7.86B Mar/2026
Nutrien USD 9.78B 505M Mar/2026
Philips EUR 6.89B 43M Mar/2026
PPG Industries USD 6.41B 195M Mar/2026
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 13.84B 1.88B Mar/2026
SAP EUR 5.04B 983M Mar/2026
Solvay EUR 1.83B 8M Mar/2026
UCB EUR 2.18B 634M Dec/2025
Umicore EUR 2.24B 10M Dec/2025
Vinci EUR 41.93B 11.14B Dec/2025